KalVista Pharmaceuticals (KALV) Assets Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 7.65% |
| Apr 30, 2025 | 6.53% |
| Oct 31, 2024 | 15.92% |
| Jul 31, 2024 | 24.86% |
| Apr 30, 2024 | 28.49% |
| Jan 31, 2024 | -43.99% |
| Oct 31, 2023 | -14.80% |
| Jul 31, 2023 | -12.06% |
| Apr 30, 2023 | -10.14% |
| Jan 31, 2023 | -9.59% |
| Oct 31, 2022 | -33.21% |
| Jul 31, 2022 | -29.64% |
| Apr 30, 2022 | -25.05% |
| Jan 31, 2022 | 239.93% |
| Oct 31, 2021 | 223.15% |
| Jul 31, 2021 | 208.85% |
| Apr 30, 2021 | 193.98% |
| Jan 31, 2021 | -35.68% |
| Oct 31, 2020 | -32.67% |
| Jul 31, 2020 | -30.01% |
| Apr 30, 2020 | -21.67% |
| Jan 31, 2020 | -18.64% |
| Oct 31, 2019 | -15.46% |
| Jul 31, 2019 | 108.07% |
| Apr 30, 2019 | 92.43% |
| Jan 31, 2019 | 89.82% |
| Oct 31, 2018 | 281.56% |
| Jul 31, 2018 | 87.17% |
| Apr 30, 2018 | 78.74% |
| Jan 31, 2018 | 75.18% |
| Mar 31, 2016 | 544.13% |
| Dec 31, 2015 | 754.77% |